EUVIMEDEUVIMED entdecken
Crossref

Synergy Effects of HPV E6‐E7 Encoding mRNA and Nucleic Acid Immunostimulators Improve Therapeutic Potential in TC‐1 Graft Tumor

Shuang He, Haiying Niu, Lizhi Zhang, Zhonge Tao, Quanxin Qu

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.70075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Shuang He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Tianjin First Central Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Oncogene Proteins, Viral, RNA, Messenger, Adjuvants, Immunologic, Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer is the second most common cancer among women globally and the most prevalent cancer in developing countries, which was caused by human papillomavirus (HPV) infection. Messenger RNA (mRNA) vaccines have opened up new avenues for vaccine development and pandemic preparedness with potent scalability, which may possess the potential antitumor effects of an mRNA‐HPV therapeutic vaccine containing nononcogenic E6 and E7 proteins. Here, we reported a lipid nanoparticle (LNP) plus nucleic acid immunostimulators (CPG 1018 and Poly I:C) mRNA vaccine platform. The LNP‐CPG 1018 capsulated HPV E6‐E7 mRNA significantly promoted the maturation of bone marrow‐derived dendritic cells (BMDC) in vitro and were capable of efficiently migrating to lymph nodes (LN) in vivo. In TC‐1 tumor‐bearing mice, the subcutaneous immunization of LNP‐CPG 1018 capsulated HPV E6‐E7 mRNA elicited robust tumor‐specific T‐cell immunity, reshaped the tumor microenvironment, and inhibited tumor growth. In conclusion, the LNP‐CPG 1018 system is a promising delivery platform for facilitating the development of HPV E6‐E7 mRNA cancer vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oncogene Proteins, ViralRNA, MessengerAdjuvants, ImmunologicNanoparticlesMice, Inbred C57BLPapillomavirus E7 ProteinsAnimalsFemaleMicePapillomavirus VaccinesDendritic CellsUterine Cervical NeoplasmsPapillomavirus InfectionsHumansCancer VaccinesT-LymphocytesPoly I-CLiposomes

Stichwörter der Autor:innen

HPVmRNA Vaccinenucleic acid immunostimulatortherapeutic vaccine

Substanzen

Oncogene Proteins, ViralRNA, MessengerAdjuvants, ImmunologicPapillomavirus E7 ProteinsPapillomavirus VaccinesLipid NanoparticlesCancer VaccinesPoly I-CLiposomes

Autor:innen und Institutionen

  • Department of Gynecology, Tianjin First Central Hospital, Tianjin, China.

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

He, S., Niu, H., Zhang, L., Tao, Z., & Qu, Q. (2024). Synergy Effects of HPV E6‐E7 Encoding mRNA and Nucleic Acid Immunostimulators Improve Therapeutic Potential in TC‐1 Graft Tumor. Journal of Medical Virology. https://doi.org/10.1002/jmv.70075

Vancouver

He S, Niu H, Zhang L, Tao Z, Qu Q. Synergy Effects of HPV E6‐E7 Encoding mRNA and Nucleic Acid Immunostimulators Improve Therapeutic Potential in TC‐1 Graft Tumor. Journal of Medical Virology. 2024. doi:10.1002/jmv.70075

BibTeX
@article{He2024,
  author = {He, Shuang and Niu, Haiying and Zhang, Lizhi and Tao, Zhonge and Qu, Quanxin},
  title = {Synergy Effects of HPV E6‐E7 Encoding mRNA and Nucleic Acid Immunostimulators Improve Therapeutic Potential in TC‐1 Graft Tumor},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.70075}
}
Kostenlos starten →